Study guide

3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function

EDAIC Part I European Diploma in Anaesthesiology and Intensive Care

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The EDAIC Part I Examination

1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy

2 Chapter 2: Anatomy for Anaesthesia and Intensive Care

2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart

3 Chapter 3: Respiratory and Cardiovascular Physiology

3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics

4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology

4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach

5 Chapter 5: Endocrine and Haematological Physiology

5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders

6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric

6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation

7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics

7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity

8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics

8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents

9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics

9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy

10 Chapter 10: Haematological and Internal Medicine Pharmacology

10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions

11 Chapter 11: Physics, Clinical Measurement and Medical Equipment

11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring

12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis

12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units

13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal

13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)

14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management

14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting

15 Chapter 15: Coexisting Disease and Preoperative Investigations

15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease

16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia

16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury

17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia

17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia

18 Chapter 18: Anaesthetic Complications and Specialty Settings

18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery

19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management

19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management

20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support

20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination

21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes

21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate

22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies

22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure

23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics

23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration

24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies

24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy

25 Chapter 25: Burns, Environmental Emergencies and Patient Transport

25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill

3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function

Key Takeaways Explain This Topic AI

The cardiac cycle encompasses ventricular systole (isovolumetric contraction, rapid ejection, reduced ejection) and diastole (isovolumetric relaxation, rapid filling, diastasis, atrial systole); atrial systole contributes 20–30% of end-diastolic volume ('atrial kick'), which becomes critical in hypertrophic, non-compliant ventricles.

On pressure-volume loops, the slope of the End-Systolic Pressure-Volume Relationship (ESPVR, E es E_{\text{es}} E es ​ ) defines ventricular contractility independent of loading conditions, while the End-Diastolic Pressure-Volume Relationship (EDPVR) reflects passive diastolic compliance; loop area quantifies stroke work.

Ventricular myocytes exhibit a 5-phase action potential driven by fast sodium influx (Phase 0, I Na I_{\text{Na}} I Na ​ ), transient outward potassium efflux (Phase 1, I to I_{\text{to}} I to ​ ), L-type calcium plateau influx (Phase 2, I Ca-L I_{\text{Ca-L}} I Ca-L ​ ), delayed rectifier potassium efflux (Phase 3, I Kr , I Ks I_{\text{Kr}}, I_{\text{Ks}} I Kr ​ , I Ks ​ ), and inward rectifier resting potassium conductance (Phase 4, I K1 I_{\text{K1}} I K1 ​ ); nodal cells display Phase 4 automaticity mediated by the funny current ( I f I_f I f ​ ).

Left ventricular coronary blood flow occurs almost exclusively during diastole ( ≈ 80 – 85 % \approx 80–85\% ≈ 80–85% ) because systolic intramyocardial tissue pressures compress subendocardial vessels; coronary perfusion pressure ( C P P = D B P − L V E D P CPP = DBP - LVEDP CPP = D BP − L V E D P ) is compromised by tachycardia, which shortens diastolic perfusion time while escalating myocardial oxygen consumption ( M V O 2 MVO_2 M V O 2 ​ ).

Last updated: October 2026

3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function

A comprehensive understanding of cardiac mechanical phases, pressure-volume loops, electrophysiological ion channels, and coronary perfusion mechanics is essential for managing acute hemodynamic instability, administering inotropes and vasopressors, and protecting the myocardium during anaesthesia.

1. Phases of the Cardiac Cycle and Pressure-Volume Loops

The cardiac cycle alternates between ventricular systole (contraction and ejection) and diastole (relaxation and filling), orchestrated by synchronized electrical activation. VENTRICULAR SYSTOLE VENTRICULAR DIASTOLE

  • +---------------------------------------+ +---------------------------------------+
  • | 1. Isovolumetric Contraction (S1) | | 4. Isovolumetric Relaxation (S2) |
  • | - All valves closed; dP/dt max | | - All valves closed; dP/dt drops |
  • | 2. Rapid Ventricular Ejection | | 5. Rapid Ventricular Filling (S3) |
  • | - Aortic/Pulmonic valves open | | - AV valves open; ~70% filling |
  • | 3. Reduced Ventricular Ejection | | 6. Diastasis (Reduced Filling) |
  • | - Outflow slows; repolarization | | 7. Atrial Systole ('Atrial Kick', S4)|
  • +---------------------------------------+ +---------------------------------------+
  • The Seven Mechanical Phases

Isovolumetric Contraction: Ventricular depolarization triggers contraction. Ventricular pressure exceeds atrial pressure, abruptly closing the atrioventricular (mitral and tricuspid) valves ( First Heart Sound, S1 ). All four valves remain closed; intraventricular volume is unchanged while pressure escalates rapidly ( d P / d t max dP/dt_{\text{max}} d P / d t max ​ ).

Rapid Ejection: Ventricular pressure surpasses aortic ( 80 mmHg 80\text{ mmHg} 80 mmHg ) and pulmonary arterial ( 10 mmHg 10\text{ mmHg} 10 mmHg ) diastolic pressures, forcing the aortic and pulmonic valves open. Approximately two-thirds of the stroke volume is rapidly propelled into the great vessels.

Reduced Ejection: Ventricular repolarization begins (T wave on ECG). The rate of ventricular pressure generation declines below aortic pressure, but forward blood flow continues briefly due to momentum. Intraventricular and aortic pressures peak and then decline.

Isovolumetric Relaxation: Ventricular pressure drops below great vessel pressures; backflow catches the valve leaflets, snapping the aortic and pulmonic valves shut ( Second Heart Sound, S2 ). All valves remain closed; volume is constant while ventricular pressure falls precipitously.

Rapid Ventricular Filling: Ventricular pressure plummets below atrial pressure, forcing the mitral and tricuspid valves open. Rapid early ventricular filling accounts for 70 − 80 % 70-80\% 70 − 80% of total end-diastolic volume. In patients with severe volume overload or poor chamber compliance, rapid deceleration of flow produces a pathological Third Heart Sound (S3) .

Diastasis (Reduced Filling): Ventricular and atrial pressures near equilibrium; passive blood flow from the systemic and pulmonary veins into the ventricles slows to a trickle.

Atrial Systole ("Atrial Kick"): P wave on ECG triggers active atrial contraction, contributing the remaining 20 − 30 % 20-30\% 20 − 30% of normal ventricular End-Diastolic Volume ( E D V EDV E D V ). In patients with non-compliant, hypertrophic ventricles (e.g. aortic stenosis, chronic hypertension), the atrial kick can contribute up to 40 % 40\% 40% of stroke volume; forceful atrial contraction against a stiff ventricular wall produces a Fourth Heart Sound (S4) . In these patients, the onset of atrial fibrillation produces acute hemodynamic collapse and pulmonary edema.

  • Jugular Venous Pulse (JVP) Tracing Pressure
  • ^
  • | /\ a-wave (Atrial contraction)
  • | / \ /\ c-wave (Tricuspid valve bulge in isovolumetric contraction)
  • | / \ / \
  • |/ x \____________________/\ v-wave (Venous filling against closed tricuspid)
  • | descent \ \
  • | (Atrial relaxation) \ \ y-descent (Tricuspid opens & empties)
  • +--------------------------------------------------------> Time

a wave: Atrial contraction (absent in atrial fibrillation; prominent cannon 'a' waves in complete heart block or junctional rhythm).

c wave: Bulging of the tricuspid valve into the right atrium during RV isovolumetric contraction.

x descent: Downward displacement of the tricuspid valve and annulus by ventricular shortening during ejection, combined with atrial relaxation.

v wave: Passive venous filling of the right atrium against the closed tricuspid valve during ventricular systole (tall 'v' waves in tricuspid regurgitation).

y descent: Rapid emptying of the right atrium into the right ventricle following tricuspid valve opening.

  • Ventricular Pressure-Volume Loops LV Pressure (mmHg)
  • 120 ^ [ESPVR] Slope = Ees (Inotropy)
  • | /------------------- [Aortic Valve Closes: ESV]
  • | /| |
  • 80 | [Aortic Opens] -/-+ |
  • | / | |
  • | / | STROKE VOLUME |
  • | / | (EDV - ESV) |
  • | / | |
  • | / | |
  • 0 +-----------/-------+------------------+---- [EDPVR] (Diastolic compliance)
  • ESV EDV
  • (Mitral Opens) (Mitral Closes)
  • --------------------> LV Volume (mL)

Stroke Volume ( S V SV S V ): Width of the loop: S V = E D V − E S V SV = EDV - ESV S V = E D V − ES V .

Stroke Work: The area enclosed by the loop represents external mechanical work performed during each cardiac contraction.

End-Systolic Pressure-Volume Relationship (ESPVR): The upper-left boundary of the loop. Its slope, termed End-Systolic Elastance ( E es E_{\text{es}} E es ​ ) , is an intrinsic, load-independent index of myocardial contractility . Positive inotropic agents (epinephrine, calcium, milrinone) steepen E es E_{\text{es}} E es ​ and shift it leftward; negative inotropes (volatile anaesthetics, beta-blockers) flatten E es E_{\text{es}} E es ​ and shift it rightward.

End-Diastolic Pressure-Volume Relationship (EDPVR): The curvilinear lower boundary reflecting passive ventricular compliance during diastole ( E = Δ P / Δ V E = \Delta P / \Delta V E = Δ P /Δ V ). Hypertrophy, ischemia, or pericardial constraint shift the EDPVR upward, meaning higher intracavitary pressures are required to achieve the same filling volume.

Arterial Elastance ( E a E_a E a ​ ): A measure of total afterload: E a ≈ End-Systolic Pressure S V E_a \approx \frac{\text{End-Systolic Pressure}}{SV} E a ​ ≈ S V End-Systolic Pressure ​ . Optimal ventriculo-arterial coupling occurs when E a / E es ≈ 0.6 − 1.0 E_a / E_{\text{es}} \approx 0.6-1.0 E a ​ / E es ​ ≈ 0.6 − 1.0 .

2. Determinants of Cardiac Output and Ventricular Interdependence

Cardiac output is governed by heart rate and stroke volume ( C O = H R × S V CO = HR \times SV CO = H R × S V ). Stroke volume is regulated by four interdependent physiological parameters:

1. Preload

Preload is the myocardial sarcomere length at the onset of contraction, clinically indexed by End-Diastolic Volume ( E D V EDV E D V ) or End-Diastolic Wall Stress.

Frank-Starling Law: Within physiological limits, increasing end-diastolic volume stretches cardiac sarcomeres toward an optimal overlap length ( ≈ 2.2 μ m \approx 2.2\,\mu\text{m} ≈ 2.2 μ m ). This stretch enhances troponin C affinity for calcium, increases cross-bridge formation, and augments stroke volume.

2. Afterload

Afterload is the wall stress or tension the ventricle must overcome during systolic ejection.

Law of Laplace for a Sphere: σ = P ⋅ r 2 h \sigma = \frac{P \cdot r}{2h} σ = 2 h P ⋅ r ​ Where σ \sigma σ is myocardial wall stress, P P P is transmural ventricular pressure, r r r is internal chamber radius, and h h h is myocardial wall thickness.

Adaptive Remodeling: In chronic hypertension or aortic stenosis (pressure overload), the ventricle adds sarcomeres in parallel, producing concentric hypertrophy ( h h h increases). This normalizes systolic wall stress σ \sigma σ . In chronic mitral or aortic regurgitation (volume overload), sarcomeres are added in series, producing eccentric hypertrophy ( r r r dilates).

3. Contractility (Inotropy)

Contractility is the intrinsic velocity and force of myocardial fiber shortening at any given preload and afterload. It is determined by the amplitude of the intracellular calcium transient (calcium-induced calcium release via ryanodine receptors) and myofilament calcium sensitivity.

4. Heart Rate

Cardiac output increases linearly with heart rate up to an optimal physiological frequency ( ≈ 140 − 160 bpm \approx 140-160\text{ bpm} ≈ 140 − 160 bpm ). Extreme tachycardia severely shortens diastole (which comprises two-thirds of the cardiac cycle at 60 bpm 60\text{ bpm} 60 bpm but falls to < 40 % <40\% < 40% at 160 bpm 160\text{ bpm} 160 bpm ), drastically limiting ventricular filling ( E D V EDV E D V falls), reducing stroke volume, and precipitating hypotension.

Ventricular Interdependence and Pericardial Constraint

The right and left ventricles share a common muscular interventricular septum and are encased within a rigid, fibrous pericardial sac of fixed volume. Consequently, the volume or geometry of one ventricle directly influences the compliance and filling of the other:

Acute RV Overload (Reverse Bernheim Effect): In acute pulmonary embolism, severe pulmonary hypertension, or RV infarction, acute RV volume expansion causes the interventricular septum to shift and bulge into the left ventricular lumen. This distorts LV geometry, markedly reduces LV compliance, impairs LV filling, and precipitates severe systemic hypotension.

Pulsus Paradoxus: During spontaneous inspiration, negative intrathoracic pressure augments RV venous return; the expanding RV shifts the septum leftward, encroaching on the LV. In cardiac tamponade or severe status asthmaticus, this septal shift produces an exaggerated inspiratory drop in systemic systolic arterial pressure ( > 10 mmHg >10\text{ mmHg} > 10 mmHg ). Under positive pressure ventilation, the hemodynamic phase reverses (reversed pulsus paradoxus).

3. Cardiac Electrophysiology: Fast vs Slow Action Potentials FAST-RESPONSE (Ventricular Myocyte) SLOW-RESPONSE (SA / AV Nodal Cell)

  • Membrane Potential (mV) Membrane Potential (mV)
  • +30 ^ Phase 1 (Ito) +10 ^
  • | /\ | Phase 0 (ICa-L)
  • 0 | / \______ Phase 2 (ICa-L, IKs) 0 | / \
  • | / \ | / \ Phase 3 (IK)
  • | / Phase 0 \ Phase 3 (IKr, IKs) -40 |-------/-----+---
  • 70 |/ (INa) \ | / |
  • 90 +----------------\------ Phase 4 (IK1) -60 +-----/-------+--- Phase 4 (If, ICa-T)
  • Fast-Response Action Potential (Atrial, Ventricular, and Purkinje Myocytes)

Phase 0 (Rapid Depolarization): Depolarization to threshold ( ≈ − 70 mV \approx -70\text{ mV} ≈ − 70 mV ) triggers opening of voltage-gated fast sodium channels ( I Na I_{\text{Na}} I Na ​ ) . Huge inward Na + \text{Na}^+ Na + current drives the membrane potential to + 20 to + 30 mV +20\text{ to }+30\text{ mV} + 20 to + 30 mV . Characterized by rapid upstroke velocity ( d V / d t max ≈ 200 − 400 V/s dV/dt_{\text{max}} \approx 200-400\text{ V/s} d V / d t max ​ ≈ 200 − 400 V/s ).

Phase 1 (Early Partial Repolarization): Fast Na + \text{Na}^+ Na + channels inactivate rapidly; voltage-gated transient outward potassium channels ( I to I_{\text{to}} I to ​ ) open briefly, moving K + \text{K}^+ K + outward.

Phase 2 (Plateau Phase): Prolonged electrical plateau ( ≈ 200 − 300 ms \approx 200-300\text{ ms} ≈ 200 − 300 ms ). Maintained by an exact equilibrium between inward calcium influx through voltage-gated L-type calcium channels ( I Ca-L I_{\text{Ca-L}} I Ca-L ​ ) and outward potassium efflux through delayed rectifier potassium channels ( I Kr I_{\text{Kr}} I Kr ​ and I Ks I_{\text{Ks}} I Ks ​ ) . Calcium entering via I Ca-L I_{\text{Ca-L}} I Ca-L ​ triggers massive calcium release from the sarcoplasmic reticulum via ryanodine receptor type 2 (RyR2; calcium-induced calcium release).

Phase 3 (Rapid Repolarization): I Ca-L I_{\text{Ca-L}} I Ca-L ​ channels inactivate, while delayed rectifier potassium channels ( I Kr I_{\text{Kr}} I Kr ​ and I Ks I_{\text{Ks}} I Ks ​ ) fully activate, producing rapid K + \text{K}^+ K + efflux that restores negative intracellular potential.

Phase 4 (Resting Membrane Potential): Stable resting potential at ≈ − 90 mV \approx -90\text{ mV} ≈ − 90 mV , maintained by high resting potassium conductance through inward rectifier potassium channels ( I K1 I_{\text{K1}} I K1 ​ ) and the electrogenic Na + / K + \text{Na}^+/\text{K}^+ Na + / K + ATPase pump ( 3 Na + 3\text{ Na}^+ 3 Na + out for 2 K + 2\text{ K}^+ 2 K + in).

Slow-Response Action Potential (SA Node and AV Node Pacemaker Cells)

Pacemaker tissue exhibits intrinsic rhythmicity (automaticity) and lacks fast sodium channels ( I Na I_{\text{Na}} I Na ​ absent) and I K1 I_{\text{K1}} I K1 ​ channels. Maximum diastolic potential is unstable, beginning at ≈ − 60 mV \approx -60\text{ mV} ≈ − 60 mV .

Phase 4 (Spontaneous Diastolic Depolarization): Characterized by slow progressive depolarization toward threshold ( ≈ − 40 mV \approx -40\text{ mV} ≈ − 40 mV ):

Funny Current ( I f I_f I f ​ ): Mediated by Hyperpolarization-activated Cyclic Nucleotide-gated (HCN4) channels. Activated by hyperpolarization at the end of repolarization; conducts a slow, inward mixed Na + / K + \text{Na}^+/\text{K}^+ Na + / K + current.

T-type Calcium Channels ( I Ca-T I_{\text{Ca-T}} I Ca-T ​ ): Transient inward calcium current opening at negative potentials (around − 50 mV -50\text{ mV} − 50 mV ), accelerating the final approach to threshold.

Phase 0 (Upstroke): Once threshold ( ≈ − 40 mV \approx -40\text{ mV} ≈ − 40 mV ) is reached, voltage-gated L-type calcium channels ( I Ca-L I_{\text{Ca-L}} I Ca-L ​ ) open slowly. Depolarization is mediated entirely by calcium influx; upstroke velocity is slow ( d V / d t ≈ 2 − 10 V/s dV/dt \approx 2-10\text{ V/s} d V / d t ≈ 2 − 10 V/s ), accounting for normal AV nodal conduction delay.

Phases 1 and 2: Absent.

Phase 3 (Repolarization): Inactivation of I Ca-L I_{\text{Ca-L}} I Ca-L ​ and activation of delayed rectifier potassium channels ( I K I_{\text{K}} I K ​ ) restores the membrane to its maximum diastolic potential ( − 60 mV -60\text{ mV} − 60 mV ).

Autonomic Control of Pacemaker Activity

Sympathetic Stimulation: Noradrenaline binds β 1 \beta_1 β 1 ​ adrenergic receptors → G s \rightarrow G_s → G s ​ protein coupling → \rightarrow → adenylyl cyclase activation → ↑ \rightarrow \uparrow →↑ cAMP. Elevated cAMP directly binds HCN channels, increasing I f I_f I f ​ channel open probability. PKA phosphorylates L-type calcium channels ( I Ca-L I_{\text{Ca-L}} I Ca-L ​ ), steepening the Phase 4 slope and accelerating conduction velocity (positive chronotropy and dromotropy). In working myocytes, PKA phosphorylates phospholamban, disinhibiting SERCA2a and speeding relaxation (positive lusitropy).

Parasympathetic Stimulation: Acetylcholine released from the vagus nerve binds M 2 M_2 M 2 ​ muscarinic receptors → G i \rightarrow G_i → G i ​ protein coupling → ↓ \rightarrow \downarrow →↓ cAMP (reducing I f I_f I f ​ ). Crucially, the G β γ G_{\beta\gamma} G β γ ​ subunit directly activates acetylcholine-activated potassium channels ( I K-ACh I_{\text{K-ACh}} I K-ACh ​ ) , causing hyperpolarization of the nodal membrane and flattening the Phase 4 slope (negative chronotropy and dromotropy).

  • 4. Coronary Blood Flow and Myocardial Oxygen Balance
  • Coronary Anatomy and Territorial Dominance

Left Main Coronary Artery: Originates from the left aortic sinus of Valsalva; bifurcates into the Left Anterior Descending (LAD) and Left Circumflex (LCx) arteries. Supplies the anterior and lateral LV walls, apex, and the anterior two-thirds of the interventricular septum.

Right Coronary Artery (RCA): Originates from the right aortic sinus of Valsalva. Supplies the RV free wall, inferior LV wall, and posterior third of the septum. Supplies the SA nodal artery in ≈ 60 % \approx 60\% ≈ 60% of patients and the AV nodal artery in ≈ 90 % \approx 90\% ≈ 90% .

Coronary Dominance: Defined by which vessel gives origin to the Posterior Descending Artery (PDA): 85 − 90 % 85-90\% 85 − 90% are right-dominant (RCA gives off PDA); 10 % 10\% 10% are left-dominant (LCx gives off PDA).

Phasic Coronary Perfusion Dynamics

Coronary perfusion is unique because the heart periodically compresses its own microvasculature:

Left Ventricle: During systole, high intramyocardial tissue pressures ( > 120 mmHg >120\text{ mmHg} > 120 mmHg in the subendocardium) collapse intramural capillaries and reverse subendocardial flow. Consequently, ≈ 80 − 85 % \approx 80-85\% ≈ 80 − 85% of left ventricular coronary blood flow occurs during diastole .

Right Ventricle: Peak systolic RV pressure is only ≈ 25 mmHg \approx 25\text{ mmHg} ≈ 25 mmHg , well below aortic systolic pressure. Therefore, right ventricular coronary perfusion is continuous across both systole and diastole .

Coronary Perfusion Pressure (CPP): C P P = D B P − L V E D P CPP = DBP - LVEDP CPP = D BP − L V E D P Where D B P DBP D BP is aortic diastolic blood pressure and L V E D P LVEDP L V E D P is left ventricular end-diastolic pressure.

The Hemodynamic Trap of Tachycardia: Tachycardia impairs myocardial oxygen supply and demand simultaneously. First, it shortens diastolic filling time per minute (reducing oxygen supply via CPP). Second, it escalates myocardial oxygen consumption per minute ( M V O 2 MVO_2 M V O 2 ​ , accelerating demand). In critical coronary stenosis, tachycardia precipitates acute subendocardial ischemia.

Myocardial Oxygen Balance ( M V O 2 MVO_2 M V O 2 ​ )

Under resting conditions, myocardial oxygen consumption is exceptionally high: 8 − 10 mL O 2 / 100 g / min 8-10\text{ mL } \text{O}_2 / 100\text{g} / \text{min} 8 − 10 mL O 2 ​ /100 g / min (accounting for ≈ 10 % \approx 10\% ≈ 10% of total body oxygen consumption despite the heart weighing only 0.5 % 0.5\% 0.5% of total body mass).

High Basal Extraction: Myocardial tissue extracts 70 − 80 % 70-80\% 70 − 80% of delivered oxygen at rest (coronary sinus saturation is only ≈ 30 % \approx 30\% ≈ 30% , with a P O 2 P\text{O}_2 P O 2 ​ of 18 − 20 mmHg 18-20\text{ mmHg} 18 − 20 mmHg ). Because extraction is already near maximal, any increase in myocardial metabolic demand must be met almost exclusively by an increase in coronary blood flow , mediated by metabolic vasodilation (adenosine, nitric oxide, K + \text{K}^+ K + , acidosis).

Determinants of M V O 2 MVO_2 M V O 2 ​ :

Heart Rate: The single most important determinant of per-minute M V O 2 MVO_2 M V O 2 ​ .

Ventricular Wall Tension / Stress: Governed by Laplace's Law (dependent on afterload/systolic pressure and cavity radius).

Inotropic State (Contractility)

Pressure Work vs Volume Work: Generating pressure against afterload consumes significantly more O 2 \text{O}_2 O 2 ​ than ejecting volume against low impedance.

Basal cellular metabolism and electrical activation: Accounts for < 20 % <20\% < 20% of total M V O 2 MVO_2 M V O 2 ​ .